Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells

Area of Science:

• Virology
• Molecular Biology
• Oncology

Background:

• Epstein-Barr virus (EBV) is linked to various diseases, including cancers.
• Detecting EBV-RNA transcripts offers diagnostic and therapeutic monitoring potential beyond EBV-DNA.
• Understanding EBV transcription is key to its pathogenic role and treatment strategies.

Purpose of the Study:

• To develop and describe a multi-gene quantitative RT-PCR profiling method for simultaneous detection of 16 crucial EBV transcripts.
• To quantify EBV RNA copies per infected cell in various sample types.
• To gain insights into EBV transcriptional activity in latent and lytic infection.

Main Methods:

• Developed a multi-gene quantitative RT-PCR assay.
• Simultaneously detected 16 key latent and lytic EBV transcripts (e.g., EBNA1, LMP1, ZEBRA, Rta).
• Quantified RNA copies per infected cell in bulk populations.

Main Results:

• Confirmed expected RNA profiles in classic EBV latency programs.
• Revealed the presence of rare cells undergoing lytic replication using a sensitive quantitative approach.
• Demonstrated the method's ability to detect transcriptional activity in both latent and lytic EBV infection.

Conclusions:

• The developed sensitive quantitative RT-PCR method provides a broader understanding of EBV transcriptional activity.
• This approach is suitable for monitoring virus-specific therapy responses in patients with EBV-associated cancers.
• Detecting lytic replication, which can induce apoptosis, offers a potential therapeutic strategy for EBV malignancies.